1. Home
  2. KMT vs NRIX Comparison

KMT vs NRIX Comparison

Compare KMT & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kennametal Inc.

KMT

Kennametal Inc.

HOLD

Current Price

$29.66

Market Cap

2.2B

Sector

Industrials

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$25.15

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KMT
NRIX
Founded
1938
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.5B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
KMT
NRIX
Price
$29.66
$25.15
Analyst Decision
Hold
Strong Buy
Analyst Count
6
12
Target Price
$36.00
$30.50
AVG Volume (30 Days)
1.3M
1.0M
Earning Date
05-06-2026
04-08-2026
Dividend Yield
2.08%
N/A
EPS Growth
268.33
N/A
EPS
4.42
N/A
Revenue
$2,356,698,000.00
$76,987,000.00
Revenue This Year
$14.24
N/A
Revenue Next Year
$7.57
$48.05
P/E Ratio
$6.75
N/A
Revenue Growth
19.82
99.31
52 Week Low
$20.35
$8.20
52 Week High
$43.81
$28.23

Technical Indicators

Market Signals
Indicator
KMT
NRIX
Relative Strength Index (RSI) 44.79 46.11
Support Level $28.40 $24.95
Resistance Level $31.15 $28.23
Average True Range (ATR) 0.84 1.03
MACD 0.16 -0.20
Stochastic Oscillator 40.66 30.60

Price Performance

Historical Comparison
KMT
NRIX

About KMT Kennametal Inc.

Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: